journal article·2025-12Open access

Delivery of 5-fluorouracil modified MicroRNAs by fucoidan-based magnetic nanoparticles to enhances tumor-localized immunotherapy and chemotherapy

Zhenzhen Deng, Jiaqi Wan, Suoqi Shan, Jing Wang, Lihua Geng, Yang Yue, Quanbin Zhang, Ning Wu

Abstract

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with an exceedingly low survival rate. It is characterized by a dense fibrotic stroma that impedes drug penetration and limits the efficacy of conventional therapies. Consequently, combining gene therapy with immunotherapy has been proposed as an innovative approach for the treatment of PDAC. Here, we designed a multifunctional nanocarrier (Fuc@miR MNPs), composed of a magnetic core surrounded by a polyethyleneimine/fucoidan shell, as a vehicle for the simultaneous targeted delivery of 5-fluorouracil (5-FU) embellished miRNA-15a mimics and fucoidan into PDAC cells. Fuc@miR MNPs have good miRNA encapsulation capacity and stable transmission efficiency. In vitro, Fuc@miR MNPs inhibited the expression of YAP-1 and Bcl-2 and released 5-FU to kill tumor cells and programmed tumor-associated macrophages (TAMs) to the M1 phenotype. In vivo, Fuc@miR MNPs were simultaneously enriched at tumor sites via magnetic navigation and p-selectin to reduce off-target effects and toxicities. Fuc@miR MNPs exerted promising antitumor activity by down-regulating the expression of oncogenes YAP-1 and Bcl-2, and alleviating the immunosuppressive tumor microenvironment. Thus, Fuc@miR MNPs are promising nanomedicines compatible with miRNA gene therapy and immunomodulation to kill tumors and improve the immunosuppressive tumor microenvironment for multidimensional treatment of PDAC. • Fuc@miR MNPs is a vehicle for the targeted delivery of 5-FU-miRNA-15a mimics. • Fuc@miR MNPs have good miRNA encapsulation capacity and stable transport efficiency. • Fuc@miR MNPs delivered drug to tumors via magnetic navigation. • Fuc@miR MNPs is a three-pronged targeted drug delivery system.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Seaweed-derived Bioactive Compounds · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
2. Longstanding postoperative fluid collection influences recurrence of pancreatic malignancy, Korean
3. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues10.1373/clinchem.2008.109603 ↗
4. miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies10.1016/j.addr.2014.09.006 ↗
5. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors10.1007/s10637-016-0407-y ↗
6. Nanomaterials for cancer precision medicine10.1002/adma.201705660 ↗
7. Nanoparticle-mediated delivery of small RNA molecules in tumor therapy10.31083/ph.2016.5735 ↗
8. Nanoparticle-based delivery of tumor suppressor microRNA for cancer therapy10.3390/cells9020521 ↗
9. Restitution of tumor suppressor miR-145 using magnetic nanoparticles inhibits pancreatic cancer10.1016/S0016-5085(16)34023-9 ↗
10. Restitution of tumor suppressor MicroRNA-145 using magnetic nanoformulation for pancreatic cancer therapy10.1007/s11605-016-3222-z ↗
11. Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer, J controlled10.1016/j.jconrel.2025.113791 ↗
12. Metal oxide nanoparticles in therapeutic regulation of macrophage functions10.3390/nano9111631 ↗
13. Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-Modified lipid-calcium carbonate nanoparticles10.1016/j.jconrel.2019.03.021 ↗
14. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA10.3109/1061186X.2011.622404 ↗
15. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses10.1158/0008-5472.CAN-12-2731 ↗
16. Tumor-associated macrophages: from mechanisms to therapy10.1016/j.immuni.2014.06.010 ↗
17. Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy10.1038/s41565-018-0146-7 ↗
18. Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment10.1016/j.carbpol.2013.02.018 ↗
19. Fucoidan-based nanoparticles: preparations and applications10.1016/j.ijbiomac.2022.07.068 ↗
20. Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer10.1016/j.ijbiomac.2022.09.201 ↗
21. Structural studies on a novel fucogalactan sulfate extracted from the brown seaweed laminaria japonica10.1016/j.ijbiomac.2010.05.010 ↗
22. Octapod iron oxide nanoparticles as high-performance T(2) contrast agents for magnetic resonance imaging10.1038/ncomms3266 ↗
23. Clinical experiences with magnetic drag targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors
24. Well-defined 3-Aminopropyltriethoxysilane functionalized magnetite nanoparticles and their adsorption performance for partially hydrolyzed polyacrylamide from aqueous solution10.1016/j.colsurfa.2019.124288 ↗
25. A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma10.1016/j.actbio.2022.11.016 ↗
26. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine10.1016/j.addr.2019.04.008 ↗
27. Tumor-associated macrophages, potential targets for cancer treatment10.1186/s40364-017-0106-7 ↗
28. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer10.1038/bjc.2013.32 ↗
29. Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo10.1371/journal.pone.0153550 ↗
30. Acute Iron deprivation reprograms human macrophage metabolism and reduces inflammation in vivo10.1016/j.celrep.2019.06.039 ↗
31. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice
32. Immunomodulation of tumor microenvironment by arginine-loaded iron oxide nanoparticles for gaseous immunotherapy10.1021/acsami.1c04638 ↗
33. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues10.1038/nnano.2016.168 ↗
34. Functional significance and therapeutic potential of miR-15a mimic in pancreatic ductal adenocarcinoma10.1016/j.omtn.2019.11.010 ↗
35. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression10.1016/j.canlet.2013.10.009 ↗
36. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model10.1016/j.biomaterials.2012.12.016 ↗
37. Local magnetic hyperthermia and systemic gemcitabine/paclitaxel chemotherapy triggers neo-angiogenesis in orthotopic pancreatic tumors without involvement of Auto/Paracrine tumor cell VEGF signaling and hypoxia10.3390/cancers16010033 ↗
38. Preclinical development of magnetic nanoparticles for hyperthermia treatment of pancreatic cancer10.1021/acsami.4c16129 ↗